EGM
Engineers Gate Manager’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,402
| Closed | -$280K | – | 2203 |
|
|
2025
Q1 | $280K | Buy |
15,402
+3,913
| +34% | +$71K | ﹤0.01% | 1747 |
|
|
2024
Q4 | $290K | Sell |
11,489
-26,997
| -70% | -$682K | 0.01% | 1714 |
|
|
2024
Q3 | $1.31M | Buy |
38,486
+30,732
| +396% | +$1.04M | 0.03% | 848 |
|
|
2024
Q2 | $287K | Sell |
7,754
-18,852
| -71% | -$698K | 0.01% | 1496 |
|
|
2024
Q1 | $1.12M | Buy |
26,606
+17,536
| +193% | +$736K | 0.03% | 763 |
|
|
2023
Q4 | $360K | Sell |
9,070
-4,583
| -34% | -$182K | 0.01% | 1351 |
|
|
2023
Q3 | $376K | Buy |
+13,653
| New | +$376K | 0.01% | 1211 |
|
|
2023
Q2 | – | Sell |
-8,227
| Closed | -$296K | – | 1767 |
|
|
2023
Q1 | $296K | Buy |
+8,227
| New | +$296K | 0.01% | 1244 |
|
|
2022
Q4 | – | Sell |
-12,317
| Closed | -$346K | – | 1714 |
|
|
2022
Q3 | $346K | Buy |
+12,317
| New | +$346K | 0.02% | 1031 |
|
|
2022
Q2 | – | Sell |
-7,086
| Closed | -$241K | – | 1951 |
|
|
2022
Q1 | $241K | Buy |
+7,086
| New | +$241K | 0.01% | 1536 |
|
|
2016
Q1 | – | Sell |
-11,030
| Closed | -$173K | – | 691 |
|
|
2015
Q4 | $173K | Buy |
+11,030
| New | +$173K | 0.01% | 612 |
|